| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 128.241.647 $ | +14.982.482 $ | +2,2 % | 7 | 172.909.369 $ | +26.134.386 $ | +751,0 % | 10 | 152.292.914 $ | +48.842.926 $ | +71,3 % | 8 | ||||
| DELCATH SYSTEMS, INC. | DCTH | → 0 | Stark | 30.627.610 $ | -2.376.280 $ | -7,2 % | 1 | 33.003.890 $ | +0 $ | +0,0 % | 1 | 33.003.890 $ | +0 $ | +0,0 % | 1 |
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 21.984.000 $ | +8.768.000 $ | +66,3 % | 1 | ||||||||
| Savara Inc | SVRA | → 0 | Stark | 17.492.317 $ | -3.032.121 $ | -14,8 % | 1 | 20.524.438 $ | +6.244.438 $ | +43,7 % | 1 | 14.280.000 $ | +8.226.728 $ | +135,9 % | 1 |
| FENNEC PHARMACEUTICALS INC. | FENC | → 0 | Schwach | 17.885.436 $ | -2.238.576 $ | -11,1 % | 1 | 20.124.012 $ | +684.790 $ | +3,5 % | 1 | 19.439.222 $ | +2.460.377 $ | +14,5 % | 1 |
| Xeris Biopharma Holdings, Inc. | XERS | → 0 | Neutral | 18.743.860 $ | +2.167.015 $ | +13,1 % | 1 | 16.576.845 $ | +1.959.310 $ | +13,4 % | 1 | 14.617.535 $ | +4.550.912 $ | +45,2 % | 1 |
| Verastem, Inc. | VSTM | → 0 | Neutral | 13.966.837 $ | -3.969.419 $ | -22,1 % | 1 | 17.936.256 $ | +9.455.470 $ | +111,5 % | 1 | ||||
| Rezolute, Inc. | RZLT | → 0 | Neutral | 17.534.058 $ | +9.768.257 $ | +125,8 % | 1 | ||||||||
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 16.851.900 $ | +16.851.900 $ | 1 | |||||||||
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Schwach | 14.004.000 $ | +1.056.000 $ | +8,2 % | 1 | ||||||||
| MediWound Ltd. | MDWD | → 0 | Neutral | 13.827.537 $ | +329.584 $ | +2,4 % | 1 | 13.497.953 $ | +5.613.182 $ | +71,2 % | 1 | ||||
| Replimune Group, Inc. | REPL | → 0 | Neutral | 13.721.576 $ | +13.538.476 $ | +7.394,0 % | 1 | ||||||||
| aTYR PHARMA INC | ATYR | → 0 | Neutral | 13.601.557 $ | +1.567.530 $ | +13,0 % | 1 | ||||||||
| CYBIN INC. | HELP | → 0 | Neutral | 13.558.677 $ | +4.723.677 $ | +53,5 % | 1 | ||||||||
| EyePoint, Inc. | EYPT | → 0 | Sehr schwach | 13.363.540 $ | +757.240 $ | +6,0 % | 1 | ||||||||
| X4 Pharmaceuticals, Inc | XFOR | → 0 | Neutral | 13.276.984 $ | +2.853.304 $ | +27,4 % | 1 | ||||||||
| 128.241.647 $ | +14.982.482 $ | +2,2 % | 7 | 172.909.369 $ | +26.134.386 $ | +751,0 % | 10 | 152.292.914 $ | +48.842.926 $ | +71,3 % | 8 | ||||